Novel mRNA-based therapy shows promise in heart regeneration after heart attack

Heart attacks remain a leading cause of death and disability worldwide. The permanent loss of heart muscle cells—known as cardiomyocytes—and the heart’s limited regenerative capacity often lead to chronic heart failure. Current treatment strategies manage symptoms but do not repair the underlying damage.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup